FLEX DIGITAL SAMPLE
LIVE

Serial Number

98842688

Owner

Luminex Corporation

Attorney

Ben Natter

Filing Date

Nov 7, 2024

Add to watchlist:

No watchlists yet
View on USPTO

FLEX DIGITAL SAMPLE Trademark

Serial Number: 98842688

FLEX DIGITAL SAMPLE is a trademark filed by Luminex Corporation on November 7, 2024. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Luminex Corporation (63 trademarks)

12212 Technology Boulevard
Austin, TX 78727

Entity Type: 03

Trademark Details

Filing Date

November 7, 2024

Registration Date

Not Registered

Published for Opposition

January 13, 2026

Goods & Services

Diagnostic testing apparatus for medical purposes for testing biomarkers and biomolecules in the respiratory and gastrointestinal systems; Diagnostic testing apparatus for medical purposes for detecting sepsis, meningitis; Medical diagnostic apparatus for medical purposes for testing diseases in the respiratory and gastrointestinal systems; Medical diagnostic apparatus for medical purposes for detecting sepsis, meningitis; Tools for medical diagnostics, namely, medical diagnostic apparatus for testing viruses and infectious disease in the respiratory and gastrointestinal systems; Tools for medical diagnostics, namely, medical diagnostic apparatus for detecting sepsis, meningitis; Medical devices for diagnosing viruses in the respiratory and gastrointestinal systems; Medical devices for detecting sepsis, meningitis; Electronic analyzers for bacterial identification for medical purposes in the respiratory and gastrointestinal systems; Electronic analyzers for detecting sepsis, meningitis for medical purposes; Apparatus for taking blood samples from the respiratory and gastrointestinal systems; Apparatus for taking blood samples to detect sepsis, meningitis; Apparatus for taking body fluid samples from the respiratory and gastrointestinal systems; Apparatus for taking body fluid samples to detect sepsis, meningitis; Point of Care (POC) diagnostic, examination, and monitoring equipment, namely, respiratory equipment and monitors therefor; Point of care (POC) immunochemical testing apparatus for carrying-out diagnostic tests for medical purposes in the respiratory and gastrointestinal systems; Point of care (POC) immunochemical testing apparatus for carrying-out diagnostic tests for detecting sepsis, meningitis; Medical diagnostic apparatus for the identification of virus, bacterial infections and infectious disease in the respiratory and gastrointestinal systems; Medical diagnostic apparatus for detecting sepsis, meningitis; Radiological diagnostic imaging apparatus for medical purposes in the field of immunochemistry, namely imaging systems for x-rays, Gram stain and parasitology; Radiological diagnostic imaging apparatus for medical purposes in the respiratory and gastrointestinal systems, namely imaging systems for x-rays, Gram stain and parasitology; Radiological diagnostic imaging apparatus for medical purposes detecting sepsis, meningitis, namely, imaging systems for x-rays, Gram stain and parasitology; Laboratory apparatus for medical diagnostic purposes in the nature of cell analyzers used for the purpose of diagnosing viruses in the respiratory and gastrointestinal systems; Laboratory apparatus for medical diagnostic purposes in the nature of cell analyzers used for detecting sepsis, meningitis; Medical diagnostic apparatus for testing for viruses in the respiratory and gastrointestinal systems; Apparatus for DNA and RNA testing for medical purposes in the respiratory and gastrointestinal systems; Apparatus for DNA and RNA testing for medical purposes for detecting sepsis, meningitis; Syringes for injections for use in the respiratory and gastrointestinal systems; Syringes for injections for the detection of sepsis, meningitis; Hypodermic syringes for medical use for use in the respiratory and gastrointestinal systems; Hypodermic syringes for medical use for detecting sepsis, meningitis; Extraction medical syringes for use in the respiratory and gastrointestinal systems extraction medical syringes for the detection of sepsis, meningitis; Syringe needles for medical purposes for use in the respiratory and gastrointestinal systems; Syringe needles for medical purposes for the detection of sepsis, meningitis; Micro-needling needles for medical purposes for use in the respiratory and gastrointestinal systems; Micro-needling needles for medical purposes for the detection of sepsis, meningitis; Medical diagnostic apparatus for the identification of pathogens responsible for syndromes of respiratory and gastrointestinal infections and diseases; Medical diagnostic apparatus for the identification of pathogens responsible for sepsis, meningitis; Molecular platform designed for the detection of pathogens through multiplex PCR nucleic acid amplification technology for use in the respiratory and gastrointestinal systems; Molecular platform designed for the detection of pathogens through multiplex PCR nucleic acid amplification technology for the detection of sepsis, meningitis

Updating of computer software in the medical diagnostic field for use in the diagnosis of disease of the respiratory and gastrointestinal systems; Updating of computer software in the medical diagnostic field for use in detecting sepsis, meningitis; Design and development of computer software in the medical diagnostic field for use in the diagnosis of disease of the respiratory and gastrointestinal systems; Design and development of computer software in the medical diagnostic field for use in detecting s sepsis, meningitis; Rental of computer software for medical diagnostic purposes for use in the diagnosis of disease of the respiratory and gastrointestinal systems; Rental of computer software for medical diagnostic purposes for use in detecting sepsis, meningitis; Maintenance and repair of computer software in the medical diagnostic field for use in the diagnosis of disease of the respiratory and gastrointestinal systems; Maintenance and repair of computer software in the medical diagnostic field for use in detecting sepsis, meningitis; Design and development of computer hardware in the medical diagnostic field for use in the diagnosis of disease of the respiratory and gastrointestinal systems; Design and development of computer hardware in the medical diagnostic field for use in detecting sepsis, meningitis; Design and development of software and hardware in the medical diagnostic field for use in the diagnosis of disease of the respiratory and gastrointestinal systems; Design and development of software and hardware in the medical diagnostic field for use in detecting sepsis, meningitis; Scientific research and development in the field of medical biotechnology for use in the diagnosis of disease of the respiratory and gastrointestinal systems; Scientific research and development in the field of medical biotechnology for use in detecting sepsis, meningitis; Research and development in the field of medical diagnostic preparations for use in the diagnosis of disease of the respiratory and gastrointestinal systems; Research and development in the field of medical diagnostic preparations for use in detecting sepsis, meningitis; Scientific laboratory services for use in the diagnosis of disease of the respiratory and gastrointestinal systems; Scientific laboratory services for use in detecting sepsis, meningitis; Chemical analysis for use in the diagnosis of disease of the respiratory and gastrointestinal systems; Chemical analysis for use in detecting sepsis, meningitis

Downloadable and recorded computer software for enabling users to electronically view test results of a user-selected subset of targets on a microarray; Downloadable computer software for mobile applications for the diagnosis of respiratory and gastrointestinal disorders and sepsis in individuals; Downloadable and recorded computer software for medical diagnostics, namely medical diagnostic test reporting, providing diagnostic test proctoring, accessing telehealth services; Downloadable and recorded computer software for operating diagnostic apparatus for the detection of pathogens, not for medical purposes; Testing machines and instruments for diagnostic purposes, other than for medical use, namely, apparatuses composed of PC tablets and optical readers for testing liquids and solids; Downloadable portable and cloud-connected POC (Point of care) immunodiagnostic software platform for diagnostic research and scientific use; Downloadable computer software and hardware for the design, creation and control of tools for medical diagnostics; Downloadable software for data processing; computer hardware and computers for diagnostics; Data processing equipment, namely, optical readers for diagnostic purposes; PC tablets used for test and diagnostic purposes; Video monitors; Testing apparatus not for medical purposes, namely, apparatus for testing liquids and solids; Measuring and testing machines and instruments for diagnostic purpose, other than for medical use, namely, apparatus composed of PC tablets and optical readers for testing liquids and solids; Research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 13, 2026 NPUB
PUBLISHED FOR OPPOSITION
Jan 13, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 7, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 11, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 9, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 9, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 9, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 18, 2025 GNRN
NON-FINAL ACTION E-MAILED
Nov 18, 2025 GNRT
NON-FINAL ACTION WRITTEN
Nov 18, 2025 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 14, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 9, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 9, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 21, 2025 GNRN
NON-FINAL ACTION E-MAILED
Aug 21, 2025 GNRT
NON-FINAL ACTION WRITTEN
Aug 21, 2025 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 7, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 7, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 7, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 16, 2025 GNRN
NON-FINAL ACTION E-MAILED
Apr 16, 2025 GNRT
NON-FINAL ACTION WRITTEN
Apr 16, 2025 CNRT
ASSIGNED TO EXAMINER
Apr 9, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 7, 2024 NWOS
NEW APPLICATION ENTERED
Nov 7, 2024 NWAP